Impact of Long COVID-19 on the Health and Quality of Life of Military Personnel (Active or Retired) and Their Families
IMP@LA
2 other identifiers
observational
10,000
1 country
1
Brief Summary
Severe and sometimes irreversible sequelae are observed in people who have developed a severe form of COVID-19 (pulmonary, cardiovascular, renal, neurological sequelae among others). More than 10% of individuals who contracted the disease, even in a mild form, still have at least one of the initial symptoms at six months, also known as prolonged symptoms or long COVID syndrome. The most frequently observed symptoms are asthenia, neurological disorders (headache, anosmia, ageusia, etc.), cardio-thoracic disorders, pain, digestive or skin disorders. Very recently, the first results of a British prospective cohort study (PHOSPCovid) indicate that more than half of the COVID-19 survivors who were hospitalised experienced a very severe to moderate deterioration in their mental and/or physical health five months after hospitalisation. Women are particularly affected. Another American study shows that 85% of non-hospitalised COVID-19 patients developed at least 4 neurological symptoms impacting their quality of life. The most common are: "brain fog" (81%), headaches (68%), numbness or tingling (60%), taste impairment (59%) and loss of smell (55%). These disabling symptoms may persist for weeks or months, deteriorating the quality of life of patients and making it difficult for some to return to a normal life. On the basis of current knowledge concerning the long-term sequelae of SARS-CoV-2 infection, it seems necessary to offer these subjects a specific care pathway and to adapt their living and working conditions beyond their medical care. The present study is aimed at measuring the impact of long COVID on the health and quality of life of the defence community (military personnel and their families).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2022
CompletedFirst Posted
Study publicly available on registry
January 21, 2022
CompletedStudy Start
First participant enrolled
September 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2023
CompletedSeptember 13, 2022
September 1, 2022
1 year
January 19, 2022
September 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of mental health events
Prevalence of mental health events will be calculated in each group, the compared: number of participants who report having experienced a mental health event (e.g. anxiety disorder) divided by the number of participants.
Until the end of the study (12 months)
Study Arms (2)
COVID+
Participants who have experienced COVID-19
COVID-
Participants who have not experienced COVID-19
Interventions
Participants will be asked to complete an online questionnaire about their health and quality of life since the start of the pandemic.
20 participants (10 from each group) will be randomly selected to participate in a semi-structured interview focusing on their perception of their health and quality of life since the start of the pandemic.
Eligibility Criteria
The study population will be composed of people affiliated to the French military health insurance, i.e., military Personnel (active or retired) and their families.
You may qualify if:
- Age ≥ 18 years-old
- Be affiliated to the French military health insurance
You may not qualify if:
- Age \< 18 years-old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre d'Epidémiologie et de Santé Publique des Armées
Marseille, 13014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2022
First Posted
January 21, 2022
Study Start
September 5, 2022
Primary Completion
September 5, 2023
Study Completion
September 5, 2023
Last Updated
September 13, 2022
Record last verified: 2022-09